POLYMORPHISM OF MEFLOQUINE HYDROCHLORIDE

被引:13
作者
KITAMURA, S [1 ]
CHANG, LC [1 ]
GUILLORY, JK [1 ]
机构
[1] UNIV IOWA, COLL PHARM, IOWA CITY, IA 52242 USA
关键词
MEFLOQUINE HYDROCHLORIDE; POLYMORPHISM; PSEUDOPOLYMORPHISM; X-RAY POWDER DIFFRACTOMETRY; THERMAL ANALYSIS; INFRARED SPECTRUM; SOLUBILITY; STABILITY;
D O I
10.1016/0378-5173(94)90084-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The polymorphic and pseudopolymorphic forms of mefloquine hydrochloride have been characterized by use of X-ray powder diffractometry, thermal analysis, infrared spectral analysis, scanning electron microscopy, and solubility measurements. It was determined that mefloquine hydrochloride can crystallize in at least eight forms, anhydrous forms (A, B', E and M), solvate forms (B and I) and hydrate forms (C and D). The acetone solvate (form B) and isopropanol solvate (form I) transform into forms B' and M, respectively, when they are heated on a hot stage. Form E, which was recrystallized from ethanol, showed gradual weight loss on heating, and a small endotherm in the DSC thermogram due to desolvation. However, the X-ray powder diffraction pattern of form E after removal of virtually all the ethanol, showed almost the same pattern. This suggests that ethanol is contained in channels within the crystal lattice of farm E. An X-ray powder diffraction study showed that the crystal forms of mefloquine hydrochloride in lots of commercial tablets obtained from two sources were forms E and C. When the tablets were stored at 60 degrees C, 75% R.H., form E was transformed into form D, but form C did not undergo a significant change. A study of the effect of various excipients on the solid-state crystal transformation revealed that microcrystalline cellulose promotes the transformation from form E into form D. However, methylcellulose, hydroxyethylcellulose, beta-cyclodextrin, crospovidone and hydrous lactose have no effect on the crystal transformation.
引用
收藏
页码:127 / 144
页数:18
相关论文
共 12 条
[1]   EFFECT OF MOISTURE ON CRYSTALLIZATION OF THEOPHYLLINE IN TABLETS [J].
ANDO, H ;
ISHII, M ;
KAYANO, M ;
OZAWA, H .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1992, 18 (04) :453-467
[2]  
BOMCHES H, 1986, Patent No. 4579855
[3]   SOLID-STATE FORMS OF PAROXETINE HYDROCHLORIDE [J].
BUXTON, PC ;
LYNCH, IR ;
ROE, JM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 42 (1-3) :135-143
[4]   THE INTERCONVERSION OF THE POLYMORPHIC FORMS OF CHLORAMPHENICOL PALMITATE (CAP) AS A FUNCTION OF ENVIRONMENTAL-TEMPERATURE [J].
DEVILLIERS, MM ;
VANDERWATT, JG ;
LOTTER, AP .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1991, 17 (10) :1295-1303
[5]   EFFECT OF ADDITIVES ON KINETICS OF INTERCONVERSION OF SULFAMETHOXYDIAZINE CRYSTAL FORMS [J].
EBIAN, AR ;
MOUSTAFA, MA ;
KHALIL, SA ;
MOTAWI, MM .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (01) :13-20
[7]   CRYSTAL-STRUCTURE AND MOLECULAR-STRUCTURE OF MEFLOQUINE METHYLSULFONATE MONOHYDRATE - IMPLICATIONS FOR A MALARIA RECEPTOR [J].
KARLE, JM ;
KARLE, IL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (11) :2238-2245
[8]   STRUCTURE OF THE ANTIMALARIAL (+/-)-MEFLOQUINE HYDROCHLORIDE [J].
KARLE, JM ;
KARLE, IL .
ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY, 1991, 47 :2391-2395
[9]  
KREMER RD, 1990, AM LAB, V22, P136
[10]  
LIM P, 1985, ANAL PROFILES DRUG S, V14, P157